Exploration of lung mycobiome in the patients with non-small-cell lung cancer

被引:13
|
作者
Zhao, Yiming [1 ,2 ]
Yi, Junqi [1 ,3 ]
Xiang, Juanjuan [3 ,4 ,5 ]
Jia, Wei [6 ]
Chen, Anqi [1 ]
Chen, Liyu [2 ]
Zheng, Leliang [4 ,5 ]
Zhou, Wen [4 ,5 ]
Wu, Minghua [4 ,5 ]
Yu, Zheng [2 ]
Tang, Jingqun [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp 2, Dept Thorac Surg, Changsha, Hunan, Peoples R China
[2] Cent South Univ, Sch Basic Med Sci, Dept Microbiol, Changsha, Hunan, Peoples R China
[3] Hunan Key Lab Early Diag & Precise Treatment Lung, Changsha, Hunan, Peoples R China
[4] Cent South Univ, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China
[5] Cent South Univ, Canc Res Inst, Sch Basic Med Sci, Chinese Minist Educ,Key Lab Carcinogenesis & Canc, Changsha, Hunan, Peoples R China
[6] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Peoples R China
基金
中国国家自然科学基金;
关键词
Non-small-cell lung cancer; Mycobiome; Alternaria arborescens; ACETALDEHYDE PRODUCTION; MICROBIOME; COMMUNITY; INFLAMMATION; INFECTIONS; IMMUNITY;
D O I
10.1186/s12866-023-02790-4
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
As the Human Microbiome Project (HMP) progresses, the relationship between microbes and human health has been receiving increasing attention. A growing number of reports support the correlation between cancer and microbes. However, most studies have focused on bacteria, rather than fungal communities. In this study, we studied the alteration in lung mycobiome in patients with non-small-cell lung cancer (NSCLC) using metagenomic sequencing and qPCR. The higher fungal diversity and more complex network were observed in the patients with NSCLC. In addition, Alternaria arborescens was found as the most relevant fungus to NSCLC, and the enrichment of it in cancerous tissue was also detected. This study proposes that the changes in fungal communities may be closely related to lung cancer, and provides insights into further exploration the relationship between lung cancer and fungi.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Exploration of lung mycobiome in the patients with non-small-cell lung cancer
    Yiming Zhao
    Junqi Yi
    Juanjuan Xiang
    Wei Jia
    Anqi Chen
    Liyu Chen
    Leliang Zheng
    Wen Zhou
    Minghua Wu
    Zheng Yu
    Jingqun Tang
    BMC Microbiology, 23
  • [2] Non-Small-Cell Lung Cancer
    不详
    GENETIC ENGINEERING & BIOTECHNOLOGY NEWS, 2008, 28 (20): : 61 - 61
  • [3] Non-small-cell lung cancer
    Cesare Gridelli
    Antonio Rossi
    David P. Carbone
    Juliana Guarize
    Niki Karachaliou
    Tony Mok
    Francesco Petrella
    Lorenzo Spaggiari
    Rafael Rosell
    Nature Reviews Disease Primers, 1
  • [4] Non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, Antonio
    Carbone, David P.
    Guarize, Juliana
    Karachaliou, Niki
    Mok, Tony
    Petrella, Francesco
    Spaggiari, Lorenzo
    Rosell, Rafael
    NATURE REVIEWS DISEASE PRIMERS, 2015, 1
  • [5] Non-small-cell lung cancer
    Hendriks, Lizza E. L.
    Remon, Jordi
    Faivre-Finn, Corinne
    Garassino, Marina C.
    Heymach, John V.
    Kerr, Keith M.
    Tan, Daniel S. W.
    Veronesi, Giulia
    Reck, Martin
    NATURE REVIEWS DISEASE PRIMERS, 2024, 10 (01):
  • [6] Exploration of oxidized phosphocholine profile in non-small-cell lung cancer
    Godzien, Joanna
    Lopez-Lopez, Angeles
    Sieminska, Julia
    Jablonowski, Kacper
    Pietrowska, Karolina
    Kisluk, Joanna
    Mojsak, Malgorzata
    Dzieciol-Anikiej, Zofia
    Barbas, Coral
    Reszec, Joanna
    Kozlowski, Miroslaw
    Moniuszko, Marcin
    Kretowski, Adam
    Niklinski, Jacek
    Ciborowski, Michal
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 10
  • [8] Non-small-cell lung cancer
    Goldstraw, Peter
    Ball, David
    Jett, James R.
    Le Chevalier, Thierry
    Lim, Eric
    Nicholson, Andrew G.
    Shepherd, Frances A.
    LANCET, 2011, 378 (9804): : 1727 - 1740
  • [9] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Kurata, Takayasu
    Okamoto, Isamu
    Tamura, Kenji
    Fukuoka, Masahiro
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 499 - 504
  • [10] Amrubicin for non-small-cell lung cancer and small-cell lung cancer
    Takayasu Kurata
    Isamu Okamoto
    Kenji Tamura
    Masahiro Fukuoka
    Investigational New Drugs, 2007, 25 : 499 - 504